Hurley Capital’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
Hurley Capital's NVO Position: Q3 2026 in Review
Hurley Capital held its Novo Nordisk (NVO) position steady in Q3 2026 at 6 shares worth $227. The position accounts for ﹤0.01% of the portfolio, ranked #628.
Hurley Capital first reported a position in NVO in Q4 2024 and has held it in 6 quarters since. The position peaked at $14K in Q4 2024. 1,237 funds tracked by Wall St. Rank hold NVO as of Q3 2026.
- Hurley Capital held 6 shares of Novo Nordisk worth $227 as of Q3 2026.
- Hurley Capital left its Novo Nordisk share count unchanged in Q3 2026.
- Novo Nordisk made up ﹤0.01% of Hurley Capital's portfolio in Q3 2026, its #628 holding.
- Hurley Capital first reported a position in Novo Nordisk in Q4 2024 and has held it in 6 quarters since.
- Hurley Capital's Novo Nordisk position peaked at $14K in Q4 2024.
- 1,237 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.
Based on Hurley Capital's 13F filing for Q3 2026, filed 5 Nov 2026.